There was a extensively accepted mechanism of metformin action that metformin could activate the LKB1/AMPK signal axis in lung cancer cell, subsequently resulting in reduced cancer cell growth and proliferation via the suppression of mTOR activity [15]. Here, MTOR is linked to lung carcinoma.